Fundz

Chemo Mouthpiece reported raising $900,000 in an initial SEC Form D filing, from an offering of $900,000

PRIVATENov 13, 2024

Amount Raised

$900,000

$900,000 sold, per SEC Form D (first sale Nov 5, 2024)

Round Type

Seed

WilmingtonHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as ChemoMouthpiece that raised within 45 days of this round, from Fundz verified event records.

  • Medmo raised $4.6M (Seed) on December 20, 2024.
  • Cytrellis Biosystems raised $25M on December 20, 2024.
  • Phio Pharmaceuticals raised $55K (Seed) on December 20, 2024.
  • Imagen Dental Partners raised $1.3M on December 20, 2024.
  • Agile Devices raised $2M (Seed) on December 19, 2024.
  • Alessa Therapeutics raised $15M (Seed) on December 19, 2024.

Who to call at ChemoMouthpiece, and when

A new round usually means ChemoMouthpiece is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ChemoMouthpiece raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ChemoMouthpiece, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ChemoMouthpiece. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ChemoMouthpiece

Location

10 RAILROAD AVENUE

Wilmington, Delaware, United States

About

Chemo Mouthpiece, LLC is an oncology supportive care company. The Chemo Mouthpiece™ device is an intraoral ice pack that delivers cryotherapy to the oral cavity of a patient receiving chemotherapy. It proactively manages and treats oral mucositis, a common and painful side effect of chemotherapy. The product was recently granted Breakthrough Device Designation by the FDA for the reduction in incidence and severity of oral mucositis caused by chemotherapy and allows patients to continue their treatment with less discomfort and disruption in their daily lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ChemoMouthpiece raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for ChemoMouthpiece's next move

See what Strategic adds

ChemoMouthpiece raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.